Literature DB >> 8030288

The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures.

G M Civitico1, S A Locarnini.   

Abstract

The transcriptional template for duck hepatitis B virus (DHBV) replication is believed to be the supercoiled covalently closed circular (CCC) molecule. DHBV CCC DNA can be amplified at least 50-fold in acutely and congenitally infected hepatocyte cultures but is normally maintained at a constant copy number in vivo infections. Here we describe experiments to determine the half-life of DHBV CCC DNA in congenitally infected hepatocyte cultures using both direct and indirect labeling of DHBV CCC DNA with the DNA labeling agent 5-bromo 2-deoxyuridine (BrUdR). Direct labeling of DHBV CCC DNA with BrUdR generated a very stable molecule with no calculable half-life. For indirect labeling experiments, hepatocytes were first cultured for 5 days in the absence of BrUdR to generate a pool of unlabeled DHBV CCC DNA, in then BrUdR was added to the culture medium. By following the fate of the pool of unlabeled CCC DNA in the cultures over time we calculated the half-life of DHBV CCC DNA to be 3 and 5 days in two separate experiments. This result suggests that there is a requirement for continuous amplification of DHBV CCC DNA to maintain a persistent chronic infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030288     DOI: 10.1006/viro.1994.1457

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.

Authors:  D Colledge; G Civitico; S Locarnini; T Shaw
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.

Authors:  W E Delaney; T G Miller; H C Isom
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

4.  Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication.

Authors:  William R Addison; Kathie-Anne Walters; Winnie W S Wong; John S Wilson; Danuta Madej; Lawrence D Jewell; D Lorne J Tyrrell
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 5.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 6.  Intracellular transport of hepatitis B virus.

Authors:  Michael Kann; Andre Schmitz; Birgit Rabe
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

7.  In vitro model for the nuclear transport of the hepadnavirus genome.

Authors:  M Kann; A Bischof; W H Gerlich
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus.

Authors:  Robert Yung-Liang Wang; Chia-Ning Shen; Min-Hui Lin; David Tosh; Chiaho Shih
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.

Authors:  I Fourel; J M Cullen; J Saputelli; C E Aldrich; P Schaffer; D R Averett; J Pugh; W S Mason
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.

Authors:  Aimee L Anderson; Krista E Banks; Marco Pontoglio; Moshe Yaniv; Alan McLachlan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.